NCT02900287

Brief Summary

Cancer survival is important to determine prognostic of patients and evaluate care and prevention health strategies. Sucre is the first study to describe cancer survival in Reunion Island. Sucre aims at evaluating five year cancer prognostic in Reunion Island by cancer site and gender. Sucre is a retrospective cohort study of cancer diagnosed between 01/01/1998 and 31/12/2008.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 14, 2016

Completed
2.3 years until next milestone

Study Start

First participant enrolled

January 1, 2019

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2019

Completed
Last Updated

January 5, 2024

Status Verified

January 1, 2024

Enrollment Period

12 months

First QC Date

September 9, 2016

Last Update Submit

January 4, 2024

Conditions

Neoplasms

Keywords

SurvivalCancer

Outcome Measures

Primary Outcomes (1)

  • 5 years related survival rate by cancer site and gender

    5 years

Secondary Outcomes (3)

  • 1, 3, 5 and 10 years related survival rate by cancer site and gender

    1, 3, 5 and 10 years

  • 1, 3, 5 and 10 years standardised survival rate by cancer site and gender

    1, 3, 5 and 10 years

  • 1, 3, 5 and 10 years related survival rate by age at diagnosis

    1, 3, 5 and 10 years

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population extracted from Reunion Island Cancer Registry

You may qualify if:

  • Patients domiciled in Reunion Island at diagnosis
  • Patients with at least 15 years of age at diagnosis
  • Patients with cancer diagnosis between 01/01/1998 and 31/12/2008

You may not qualify if:

  • Cutaneous malignant cancer expected melanoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de La Réunion

Saint-Denis, 97400, Reunion

Location

MeSH Terms

Conditions

Neoplasms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2016

First Posted

September 14, 2016

Study Start

January 1, 2019

Primary Completion

December 31, 2019

Study Completion

December 31, 2019

Last Updated

January 5, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations

RE(1)